Sign up for email alerts for Press Releases and Advaxis' breaking news.
Advaxis is a clinical-stage biotechnology company
focused on the development and commercialization of proprietary Lm-based antigen delivery products. These immunotherapies are based on a platform technology that utilizes live attenuated Listeria monocytogenes (Lm) bioengineered to secrete antigen/adjuvant fusion proteins.